The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Perampanel is a prescription medication used for the treatment of partial-onset and tonic-clonic seizures
Global Perampanel market is projected to reach US$ 888.1 million in 2029, increasing from US$ 450 million in 2022, with the CAGR of 10.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Perampanel market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Perampanel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Intas Pharma
Clinigen Group
Eisai
Alkaloida Chemical
Teva Pharma
ELPEN
CDMD
Qingfeng Pharma
Healthnice
Segment by Type
2Mg
4Mg
6Mg
10Mg
Segment by Application
Localized Seizures
Tonic-Clonic Seizures
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Perampanel report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Perampanel is a prescription medication used for the treatment of partial-onset and tonic-clonic seizures
Global Perampanel market is projected to reach US$ 888.1 million in 2029, increasing from US$ 450 million in 2022, with the CAGR of 10.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Perampanel market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Perampanel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Intas Pharma
Clinigen Group
Eisai
Alkaloida Chemical
Teva Pharma
ELPEN
CDMD
Qingfeng Pharma
Healthnice
Segment by Type
2Mg
4Mg
6Mg
10Mg
Segment by Application
Localized Seizures
Tonic-Clonic Seizures
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Perampanel report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Perampanel Market Overview
1.1 Product Overview and Scope of Perampanel
1.2 Perampanel Segment by Type
1.2.1 Global Perampanel Market Value Comparison by Type (2023-2029)
1.2.2 2Mg
1.2.3 4Mg
1.2.4 6Mg
1.2.5 10Mg
1.3 Perampanel Segment by Application
1.3.1 Global Perampanel Market Value by Application: (2023-2029)
1.3.2 Localized Seizures
1.3.3 Tonic-Clonic Seizures
1.4 Global Perampanel Market Size Estimates and Forecasts
1.4.1 Global Perampanel Revenue 2018-2029
1.4.2 Global Perampanel Sales 2018-2029
1.4.3 Global Perampanel Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Perampanel Market Competition by Manufacturers
2.1 Global Perampanel Sales Market Share by Manufacturers (2018-2023)
2.2 Global Perampanel Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Perampanel Average Price by Manufacturers (2018-2023)
2.4 Global Perampanel Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Perampanel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Perampanel, Product Type & Application
2.7 Perampanel Market Competitive Situation and Trends
2.7.1 Perampanel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Perampanel Players Market Share by Revenue
2.7.3 Global Perampanel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Perampanel Retrospective Market Scenario by Region
3.1 Global Perampanel Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Perampanel Global Perampanel Sales by Region: 2018-2029
3.2.1 Global Perampanel Sales by Region: 2018-2023
3.2.2 Global Perampanel Sales by Region: 2024-2029
3.3 Global Perampanel Global Perampanel Revenue by Region: 2018-2029
3.3.1 Global Perampanel Revenue by Region: 2018-2023
3.3.2 Global Perampanel Revenue by Region: 2024-2029
3.4 North America Perampanel Market Facts & Figures by Country
3.4.1 North America Perampanel Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Perampanel Sales by Country (2018-2029)
3.4.3 North America Perampanel Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Perampanel Market Facts & Figures by Country
3.5.1 Europe Perampanel Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Perampanel Sales by Country (2018-2029)
3.5.3 Europe Perampanel Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Perampanel Market Facts & Figures by Country
3.6.1 Asia Pacific Perampanel Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Perampanel Sales by Country (2018-2029)
3.6.3 Asia Pacific Perampanel Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Perampanel Market Facts & Figures by Country
3.7.1 Latin America Perampanel Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Perampanel Sales by Country (2018-2029)
3.7.3 Latin America Perampanel Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Perampanel Market Facts & Figures by Country
3.8.1 Middle East and Africa Perampanel Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Perampanel Sales by Country (2018-2029)
3.8.3 Middle East and Africa Perampanel Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Perampanel Sales by Type (2018-2029)
4.1.1 Global Perampanel Sales by Type (2018-2023)
4.1.2 Global Perampanel Sales by Type (2024-2029)
4.1.3 Global Perampanel Sales Market Share by Type (2018-2029)
4.2 Global Perampanel Revenue by Type (2018-2029)
4.2.1 Global Perampanel Revenue by Type (2018-2023)
4.2.2 Global Perampanel Revenue by Type (2024-2029)
4.2.3 Global Perampanel Revenue Market Share by Type (2018-2029)
4.3 Global Perampanel Price by Type (2018-2029)
5 Segment by Application
5.1 Global Perampanel Sales by Application (2018-2029)
5.1.1 Global Perampanel Sales by Application (2018-2023)
5.1.2 Global Perampanel Sales by Application (2024-2029)
5.1.3 Global Perampanel Sales Market Share by Application (2018-2029)
5.2 Global Perampanel Revenue by Application (2018-2029)
5.2.1 Global Perampanel Revenue by Application (2018-2023)
5.2.2 Global Perampanel Revenue by Application (2024-2029)
5.2.3 Global Perampanel Revenue Market Share by Application (2018-2029)
5.3 Global Perampanel Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Intas Pharma
6.1.1 Intas Pharma Corporation Information
6.1.2 Intas Pharma Description and Business Overview
6.1.3 Intas Pharma Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Intas Pharma Perampanel Product Portfolio
6.1.5 Intas Pharma Recent Developments/Updates
6.2 Clinigen Group
6.2.1 Clinigen Group Corporation Information
6.2.2 Clinigen Group Description and Business Overview
6.2.3 Clinigen Group Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Clinigen Group Perampanel Product Portfolio
6.2.5 Clinigen Group Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Corporation Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eisai Perampanel Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Alkaloida Chemical
6.4.1 Alkaloida Chemical Corporation Information
6.4.2 Alkaloida Chemical Description and Business Overview
6.4.3 Alkaloida Chemical Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Alkaloida Chemical Perampanel Product Portfolio
6.4.5 Alkaloida Chemical Recent Developments/Updates
6.5 Teva Pharma
6.5.1 Teva Pharma Corporation Information
6.5.2 Teva Pharma Description and Business Overview
6.5.3 Teva Pharma Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Pharma Perampanel Product Portfolio
6.5.5 Teva Pharma Recent Developments/Updates
6.6 ELPEN
6.6.1 ELPEN Corporation Information
6.6.2 ELPEN Description and Business Overview
6.6.3 ELPEN Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.6.4 ELPEN Perampanel Product Portfolio
6.6.5 ELPEN Recent Developments/Updates
6.7 CDMD
6.6.1 CDMD Corporation Information
6.6.2 CDMD Description and Business Overview
6.6.3 CDMD Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CDMD Perampanel Product Portfolio
6.7.5 CDMD Recent Developments/Updates
6.8 Qingfeng Pharma
6.8.1 Qingfeng Pharma Corporation Information
6.8.2 Qingfeng Pharma Description and Business Overview
6.8.3 Qingfeng Pharma Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Qingfeng Pharma Perampanel Product Portfolio
6.8.5 Qingfeng Pharma Recent Developments/Updates
6.9 Healthnice
6.9.1 Healthnice Corporation Information
6.9.2 Healthnice Description and Business Overview
6.9.3 Healthnice Perampanel Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Healthnice Perampanel Product Portfolio
6.9.5 Healthnice Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Perampanel Industry Chain Analysis
7.2 Perampanel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Perampanel Production Mode & Process
7.4 Perampanel Sales and Marketing
7.4.1 Perampanel Sales Channels
7.4.2 Perampanel Distributors
7.5 Perampanel Customers
8 Perampanel Market Dynamics
8.1 Perampanel Industry Trends
8.2 Perampanel Market Drivers
8.3 Perampanel Market Challenges
8.4 Perampanel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
